Kalvista Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$17.00

+0.57 (+3.47%)

As of Mar 22, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +280.9% upside

Low Target $35.35

Average Target $64.76

High Target $75.74

Current Price $17.00

Current
$17.00

Target
$64.76

$35.35 $64.76 avg $75.74

Scenario Analysis

Bear Case

$35.35

107.9%

Low target

Base Case

$64.76

+280.9%

Avg target

Bull Case

$75.74

+345.5%

High target

Risk/Reward

3.2x

Highly favorable

Price in Context

52-Week High

$19.00

-10.5% from high

52-Week Low

$9.24

+84.1% from low

Target vs 52W High

$64.76

+240.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%